| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5582086 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 5 Pages |
Abstract
In our study population, the achievement of a MMR and CCyR and overall survival, progression-free survival, and event-free survival were similar to previous published data. Reaching high survival rates with a first-generation TKI in a country with limited resources is a reasonable treatment approach for CML patients.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Marcel Massoud, Riwa Sakr, Fouad Kerbage, Joseph Makdissi, Jenny Hawi, Layale Rached, Fady Nasr, Georges Chahine,